Delphia (USA)’s Myovant Sciences Ltd. MYOV Stock Holding History

Delphia (USA)’s Portfolio MYOV Stock Details MYOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-10,456	Closed	-$163K	–	422
2021 Q4	$163K	Buy	+10,456	New	+$200K	0.17%	232

Other funds holding MYOV

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Delphia (USA)'s MYOV Position: Q1 2022 in Review

Delphia (USA) sold out of Myovant Sciences Ltd. (MYOV) in Q1 2022, closing a stake of 10,456 shares — an estimated $163K sold.

Delphia (USA) first reported a position in MYOV in Q4 2021 and held it in 1 quarter. The position peaked at $163K in Q4 2021. 89 funds tracked by Wall St. Rank hold MYOV as of Q1 2022.

Delphia (USA) reported no remaining Myovant Sciences Ltd. position as of Q1 2022 after selling out during the quarter.
Delphia (USA) sold 10,456 Myovant Sciences Ltd. shares in Q1 2022, an estimated $163K.
Delphia (USA) first reported a position in Myovant Sciences Ltd. in Q4 2021 and held it in 1 quarter.
Delphia (USA)'s Myovant Sciences Ltd. position peaked at $163K in Q4 2021.
89 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q1 2022.

Based on Delphia (USA)'s 13F filing for Q1 2022, filed 16 May 2022.